pmc logo imageJournal ListSearchpmc logo image
Logo of cvmNow Published as Trials.BioMed Central web siteSearch.Manuscript submission.Registration.Journal front page.
Other Issues:  previous | next | latest | archive
Volume 2(6);  2001
Commentaries
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
Philip L Hooper
Curr Control Trials Cardiovasc Med. 2001; 2(6): 251–253. Published online 2001 September 20. doi: 10.1186/cvm-2-6-251.
PMCID: PMC64823
Comments on ALLHAT and doxazosin
Lawrence R Krakoff
Curr Control Trials Cardiovasc Med. 2001; 2(6): 254–256. Published online 2001 November 1. doi: 10.1186/cvm-2-6-254.
PMCID: PMC64824
Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
Irene Gavras and Haralambos Gavras
Curr Control Trials Cardiovasc Med. 2001; 2(6): 257–259. Published online 2001 November 3. doi: 10.1186/cvm-2-6-257.
PMCID: PMC64825
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
Deepak L Bhatt and Eric J Topol
Curr Control Trials Cardiovasc Med. 2001; 2(6): 260–262. Published online 2001 October 25. doi: 10.1186/cvm-2-6-260.
PMCID: PMC64821
Debate: PCI vs CABG: a moving target, but we are gaining
David R Holmes, Jr
Curr Control Trials Cardiovasc Med. 2001; 2(6): 263–265. Published online 2001 November 28. doi: 10.1186/cvm-2-6-263.
PMCID: PMC64826
Debate: Should statin be used in patients with heart failure?
Aldo Pietro Maggioni
Curr Control Trials Cardiovasc Med. 2001; 2(6): 266–267. Published online 2001 November 27. doi: 10.1186/cvm-2-6-266.
PMCID: PMC64827
Debate: Statins should be used in patients with heart failure
John Kjekshus
Curr Control Trials Cardiovasc Med. 2001; 2(6): 268–270. Published online 2001 November 28. doi: 10.1186/cvm-2-6-268.
PMCID: PMC64828
Reviews
Cytokines as new treatment targets in chronic heart failure
Jan Kristian Damås, Lars Gullestad, and Pål Aukrust
Curr Control Trials Cardiovasc Med. 2001; 2(6): 271–277. Published online 2001 October 16. doi: 10.1186/cvm-2-6-271.
PMCID: PMC64832
Therapeutic angiogenesis for cardiovascular disease
Yin-Shan Ng and Patricia A D'Amore
Curr Control Trials Cardiovasc Med. 2001; 2(6): 278–285. Published online 2001 October 24. doi: 10.1186/cvm-2-6-278.
PMCID: PMC64829
Distal protection devices during percutaneous coronary and carotid interventions
Panayotis Fasseas, James L Orford, Ali E Denktas, and Peter B Berger
Curr Control Trials Cardiovasc Med. 2001; 2(6): 286–291. Published online 2001 November 23. doi: 10.1186/cvm-2-6-286.
PMCID: PMC64830
Biventricular pacing in heart failure: update on results from clinical trials
Guy Haywood
Curr Control Trials Cardiovasc Med. 2001; 2(6): 292–297. Published online 2001 November 28. doi: 10.1186/cvm-2-6-292.
PMCID: PMC64831
Research
How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)
Lutgarde Thijs, Jan A Staessen, Sonia Beleva, Willem H Birkenhäger, Christopher J Bulpitt, Hilde Celis, Astrid E Fletcher, Rumjana Kermova, Gastone Leonetti, Tovio Laks, Stefan Mantov, Choudomir Nachev, Cinzia Sarti, Jaakko Tuomilehto, Robert H Fagard, and on behalf of the Systolic Hypertension in Europe Investigators
Curr Control Trials Cardiovasc Med. 2001; 2(6): 298–306. Published online 2001 October 18. doi: 10.1186/cvm-2-6-298.
PMCID: PMC64833
Editorial
A new era in hypertension research: discussing the findings of ALLHAT
Curt D Furberg
Curr Control Trials Cardiovasc Med. 2001; 2(6): 249–250. Published online 2001 November 28. doi: 10.1186/cvm-2-6-249.
PMCID: PMC64822
Other Issues:  previous | next | latest | archive
Articles from Current Controlled Trials in Cardiovascular Medicine are provided here courtesy of
BioMed Central